Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Efficacy of a New Small-Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) in Preclinical Models of B-Cell Lymphoma and Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 5383.

https://doi.org/10.1182/blood-2018-99-111578

Published: 2018

Journal Articles

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Josep Muncunill, MSc, Maria Joao Baptista, PhD PharmD, Agueda Hernandez-Rodriguez, PhD, Judith Dalmau, PhD, Gustavo Tapia, MD PhD, Olga Garcia, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Javier Martinez-Picado, PhD, Josep-Maria Ribera, MD, Evarist Feliu, MD PhD, Jose-Luis Mate, MD PhD, Jose Tomas Navarro, MD PhD

Blood (2017) 130 (Supplement 1): 4004.

https://doi.org/10.1182/blood.V130.Suppl_1.4004.4004

Published: 2017

Journal Articles

Use of Bortezomib-Containing Regimens in the Frontline Treatment of Patients with Plasmablastic Lymphoma: A Multicenter Retrospective Analysis

Thomas Guerrero, MD, Michele Bibas, MD, Franco Baldini, MD, Guillaume Cartron, Kate Cwynarski, MD, Daan Dierickx, MD PhD, Frederick Lansigan, MD, Yevgeniy A Linnik, MD, Renzo Mogollon, MD, Jose Tomas Navarro, MD PhD, Slavisa Ninkovic, MBBS FRACP FRCPA, Adam J Olszewski, MD, John L. Reagan, MD, Emmanuelle Tchernonog, MD, Thomas Tousseyn, MD PhD, Jorge J. Castillo, MD

Blood (2017) 130 (Supplement 1): 1580.

https://doi.org/10.1182/blood.V130.Suppl_1.1580.1580

Published: 2017

Journal Articles

Gene Rearrangements and Other Molecular Features in Aggressive B-Cell Lymphomas of Patients with and without HIV-Infection

Maria Joao Baptista, PharmD, PhD, Gustavo Tapia, MD, Ana-Maria Muñoz-Marmol, PhD, Olga Garcia, MD, Josep Muncunill, MSc, Maria-Jose Terol, MD PhD, Eva González-Barca, MD PhD, Pilar Miralles, MD PhD, Ferran Vall-Llovera, MD, Mariano Provencio, MD PhD, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Jose-Luis Mate, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD, Jose-Tomas Navarro, MD PhD

Blood (2015) 126 (23): 3874.

https://doi.org/10.1182/blood.V126.23.3874.3874

Published: 2015

Journal Articles

Prevalence, Predictive Factors Therapy and Outcome of Patients with Follicular Lymphoma Refractory to First Line Immunochemotherapy

Marc Sorigue, MD, Juan-Manuel Sancho, Santiago Mercadal, MD, Ruben Fernández-Álvarez, MD, Helena Pomares, MD, Olga Garcia, Eva González-Barca, MD PhD, Esther González-García, MD, Miriam Moreno, MD, Cristina Motlló, MD, Montserrat García, MD, Jose-Tomas Navarro, MD PhD, Eva domingo-Domenech, MD, Evarist Feliu, MD PhD, Anna Sureda, MD PhD, Josep-Maria Ribera, MD PhD

Blood (2015) 126 (23): 1510.

https://doi.org/10.1182/blood.V126.23.1510.1510

Published: 2015

Journal Articles

Advanced Stage Hodgkin’s Lymphoma Has More Aggressive Characteristics but Similar Outcome in HIV-Infected Than in HIV-Negative Patients in the Combination Antiretroviral Therapy Era

Jose-Tomas Navarro, MD PhD, Marc Sorigue, MD, Blanca Xicoy, MD PhD, Olga Garcia, Maria Joao Baptista, PhD, Juan-Manuel Sancho, MD PhD, Jose-Luis Mate, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD

Blood (2014) 124 (21): 4435.

https://doi.org/10.1182/blood.V124.21.4435.4435

Published: 2014

Journal Articles

Epstein-Barr Virus Viral Loads and Serum Free Light Chains Levels Are Diagnostic Markers of Lymphoma in HIV-Infected Patients

Maria Joao Baptista, PhD, Mireia Morgades, Agueda Hernandez, MD, Albert Briega, Eva Martinez, MD PhD, Javier Martinez-Picado, PhD, Guillem Sirera, MD PhD, Gustavo Tapia, MD, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD, Jose-Tomas Navarro, MD PhD

Blood (2014) 124 (21): 1697.

https://doi.org/10.1182/blood.V124.21.1697.1697

Published: 2014

Journal Articles

Clinical and Biological Features Of Monoclonal B-Cell Lymphocytosis In Patients Referred To Hospital

Ines Rodriguez-Hernandez, Jordi Junca, MD, Jose-Tomas Navarro, MD, PhD, Isabel Granada, Evarist Feliu, MD, PhD, Fuensanta Milla, MD, PhD, Josep-Maria Ribera, MD, PhD

Blood (2013) 122 (21): 5298.

https://doi.org/10.1182/blood.V122.21.5298.5298

Published: 2013

Journal Articles

Differences In Clinical-Biological Features and Outcome Between Diffuse Large B-Cell Lymphomas Of HIV-Infected and Non-HIV-Infected Patients Treated With RCHOP In The CART Era

Maria Joao Baptista, PhD, Mireia Morgades, Olga Garcia, Miriam Moreno, MD, Juan Manuel Sancho, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD, Josep-Maria Ribera, MD, PhD, Jose-Tomas Navarro, MD, PhD

Blood (2013) 122 (21): 1815.

https://doi.org/10.1182/blood.V122.21.1815.1815

Published: 2013

Journal Articles

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Jose-Tomas Navarro, MD, PhD, Maria Joao Baptista, PhD, Alejandra Martinez-Trillos, MD, Gustavo Tapia, MD, Jose Angel Hernandez-Rivas, MD, PhD, Olga Garcia, Anna Muñoz-Marmol, PhD, Juan-Manuel Sancho, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD, Jose-Luis Mate, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Josep-Maria Ribera, MD, PhD

Blood (2013) 122 (21): 5083.

https://doi.org/10.1182/blood.V122.21.5083.5083

Published: 2013

Journal Articles

Multilineage Dysplasia Confers Poor Prognosis to Patients with De Novo Acute Myeloid Leukemia with Intermediate-Risk Cytognetics and Wild-Type NPM1 .

Jose Tomas Navarro, MD; PhD, Maria Rozman, MD, PhD, Leonor Arenillas, Ana Aventin, Teresa Gimenez, MD, Esther Alonso, MD, PhD, Granada Perea, MD; PhD, Mireia Camós, MD, PhD, Mayda Navarrete, MD, Esperanza Tuset, MD, Lourdes Florensa, MD, Fuensanta Millá, MD, PhD, Josep F Nomdedeu, MD, Esmeralda de la Banda, MD, Marina Díaz-Beyá, MD, Salut Brunet, Jorge Sierra, MD, PhD, Jordi Esteve, MD, PhD

Blood (2012) 120 (21): 2551.

https://doi.org/10.1182/blood.V120.21.2551.2551

Published: 2012

Journal Articles

Clinical and Biological Characteristics According to the Burden of JAK2V617F Mutated Allele in BCR-ABL Negative MPNs

Blood (2012) 120 (21): 1437.

https://doi.org/10.1182/blood.V120.21.1437.1437

Published: 2012

Journal Articles

A Pooled Analysis of 1,546 Patients with HIV-Associated Lymphoma: Assessment of Lymphoma-, HIV-, and Treatment-Specific Factors On Clinical Outcomes

Blood (2012) 120 (21): 3682.

https://doi.org/10.1182/blood.V120.21.3682.3682

Published: 2012

Journal Articles

Frequency and Prognosis of Clonal Chromosomal Abnormalities Following Stem Cell Transplantation (SCT) in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Blood (2011) 118 (21): 4897.

https://doi.org/10.1182/blood.V118.21.4897.4897

Published: 2011

Journal Articles

Second Malignancies After Treatment of AIDS-Related Non-Hodgking's Lymphoma

Jose Tomas Navarro, MD, PhD, Maria Joao Baptista, Mireia Morgades, Cristina Tural, MD, PhD, Evarist Feliu, MD, PhD, Fuensanta Millá, MD, PhD, Josep-Maria Ribera, MD, PhD

Blood (2011) 118 (21): 4943.

https://doi.org/10.1182/blood.V118.21.4943.4943

Published: 2011

Journal Articles

Role of ABL Gene Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib and Results of Treatment Shift to Second-Generation Tyrosine Kinase Inhibitors

Blood (2011) 118 (21): 4442.

https://doi.org/10.1182/blood.V118.21.4442.4442

Published: 2011

NARROW

Efficacy of a New Small-Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) in Preclinical Models of B-Cell Lymphoma and Acute Myeloid Leukemia

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Use of Bortezomib-Containing Regimens in the Frontline Treatment of Patients with Plasmablastic Lymphoma: A Multicenter Retrospective Analysis

Gene Rearrangements and Other Molecular Features in Aggressive B-Cell Lymphomas of Patients with and without HIV-Infection

Prevalence, Predictive Factors Therapy and Outcome of Patients with Follicular Lymphoma Refractory to First Line Immunochemotherapy

Advanced Stage Hodgkin’s Lymphoma Has More Aggressive Characteristics but Similar Outcome in HIV-Infected Than in HIV-Negative Patients in the Combination Antiretroviral Therapy Era

Epstein-Barr Virus Viral Loads and Serum Free Light Chains Levels Are Diagnostic Markers of Lymphoma in HIV-Infected Patients

Clinical and Biological Features Of Monoclonal B-Cell Lymphocytosis In Patients Referred To Hospital

Differences In Clinical-Biological Features and Outcome Between Diffuse Large B-Cell Lymphomas Of HIV-Infected and Non-HIV-Infected Patients Treated With RCHOP In The CART Era

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Multilineage Dysplasia Confers Poor Prognosis to Patients with De Novo Acute Myeloid Leukemia with Intermediate-Risk Cytognetics and Wild-Type NPM1 .

Clinical and Biological Characteristics According to the Burden of JAK2V617F Mutated Allele in BCR-ABL Negative MPNs

A Pooled Analysis of 1,546 Patients with HIV-Associated Lymphoma: Assessment of Lymphoma-, HIV-, and Treatment-Specific Factors On Clinical Outcomes

Frequency and Prognosis of Clonal Chromosomal Abnormalities Following Stem Cell Transplantation (SCT) in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Second Malignancies After Treatment of AIDS-Related Non-Hodgking's Lymphoma

Role of ABL Gene Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib and Results of Treatment Shift to Second-Generation Tyrosine Kinase Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only